Showing results (41-50 of 132) with videos related to
Sort By:
Pageof 14
Molecular Cancer Therapeutics|December 3, 2011
Coexistence of PIK3CA and other oncogene mutations in lung adenocarcinoma-rationale for comprehensive mutation profilingJamie E Chaft, Maria E Arcila, Paul K Paik, et al.JAMA Network Open|December 9, 2025
Risk and Outcomes of Secondary Cancer Among Lung Cancer Survivors After Definitive TreatmentMatthew T McMillan, Orly Yariv, Sana Raoof, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 12, 2015
Solid Predominant Histologic Subtype in Resected Stage I Lung Adenocarcinoma Is an Independent Predictor of Early, Extrathoracic, Multisite Recurrence and of Poor Postrecurrence SurvivalHideki Ujiie, Kyuichi Kadota, Jamie E Chaft, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 1, 2012
Distinct profile of driver mutations and clinical features in immunomarker-defined subsets of pulmonary large-cell carcinomaNatasha Rekhtman, Laura J Tafe, Jamie E Chaft, et al.Advances in Radiation Oncology|September 12, 2018
Safety of combining thoracic radiation therapy with concurrent versus sequential immune checkpoint inhibitionDonata von Reibnitz, Jamie E Chaft, Abraham J Wu, et al.Clinical Lung Cancer|July 22, 2014
Phase II study of the GI-4000 KRAS vaccine after curative therapy in patients with stage I-III lung adenocarcinoma harboring a KRAS G12C, G12D, or G12V mutationJamie E Chaft, Anya Litvak, Maria E Arcila, et al.Medrxiv : the Preprint Server for Health Sciences|November 24, 2025
Thymus Composition Predicts Pneumonitis Risk in Lung Cancer TherapyTafadzwa L Chaunzwa, Gokul Krishnan, Kwadwo Amoako-Boadu, et al.Advances in Radiation Oncology|March 5, 2021
Genomic Analyses for Predictors of Response to Chemoradiation in Stage III Non-Small Cell Lung CancerLeo Y Luo, Robert M Samstein, Rosalind Dick-Godfrey, et al.International Journal of Radiation Oncology, Biology, Physics|February 14, 2022
Effects of Tumor Mutational Burden and Gene Alterations Associated with Radiation Response on Outcomes of Postoperative Radiation Therapy in Non-Small Cell Lung CancerNarek Shaverdian, Annemarie F Shepherd, Xingzhe Li, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 14, 2023
Neoadjuvant Targeted Therapy in Resectable NSCLC: Current and Future PerspectivesJay M Lee, Ciaran J McNamee, Eric Toloza, et al.Pageof 14